Rapid Novor will be attending Peptalk 2018 conference January 8 – 12, at Hilton San Diego Bayfront, San Diego, California.

Our co-founder and CEO, Mingjie, will give a talk at 11:30am on Thursday. Mingjie will talk about the goal, the challenges and our approach in developing REmAb™, the world’s most advanced antibody protein sequencing platform. He will then dive deeper into a few key technology aspects and share the experiences and best practices we developed during our journey.

We invite you for a discussion at our booth # 516. Or you can always setup a meeting with us on how we may help in your research project via this form.

Sign up for the newsletter.

Sign up for the next webinar.

Whitepaper: Prevalence of Secondary Light Chains

Talk to Our Scientists.

We Have Sequenced 3000+ Antibodies and We Are Eager to Help You.

Through next generation protein sequencing, Rapid Novor enables reliable discovery and development of novel reagents, diagnostics, and therapeutics. Thanks to our Next Generation Protein Sequencing and antibody discovery services, researchers have furthered thousands of projects, patented antibody therapeutics, and developed the first recombinant polyclonal antibody diagnostics.

Talk to Our Scientists.

We Have Sequenced 3000+ Antibodies and We Are Eager to Help You.

Through next generation protein sequencing, Rapid Novor enables timely and reliable discovery and development of novel reagents, diagnostics, and therapeutics. Thanks to our Next Generation Protein Sequencing and antibody discovery services, researchers have furthered thousands of projects, patented antibody therapeutics, and ran the first recombinant polyclonal antibody diagnostics

Talk to our scientists. We have sequenced over 3000 antibodies and we are eager to help you.